Recent News Releases
This section includes a wide variety of news including media releases, photo and video galleries, fact sheets and publications.
- ‘Complete the course’ message for antibiotics should be dropped
- Ovarian cancer: Statins might be effective with diet control
- Ashwagandha: Health benefits and side effects
- Study finds rate of medication errors resulting in serious medical outcomes rising
- Common heartburn drugs tied to higher risk of death
LATEST NEWS
- Evaluation of responsiveness to reduced-dose rituximab in corticotropin/ivig/rituximab combination immunotherapy for opsoclonus-myoclonus syndrome
- Phase II study of single-agent cabozantinib in patients with recurrent clear cell ovarian, primary peritoneal or fallopian tube cancer (NRG-GY001)
- Erlotinib in combination with bevacizumab has potential benefit in non-small cell lung cancer: A systematic review and meta-analysis of randomized clinical trials
- Epidemiology and etiology of invasive bacterial infection in infants ≤60 days old treated in Emergency Departments
- Treprostinil improves persistent pulmonary hypertension associated with congenital diaphragmatic hernia
PHARMACOLOGY
- Use of histamine H<sub>2</sub> receptor antagonists and outcomes in patients with heart failure: A nationwide population-based cohort study
- The effectiveness of trimetazidine treatment in patients with stable angina pectoris of various durations: Results from the CHOICE-2 Study
- Association of alendronate and risk of cardiovascular events in patients with hip fracture
- Meta-analysis comparing dual vs single antiplatelet therapy in combination with antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation
- Self-reported non-adherence to medication in Japanese patients with cardiovascular diseases
CLINICAL PHARMACOLOGY
- Iodine quantification to distinguish hepatic neuroendocrine tumor metastasis from hepatocellular carcinoma at dual-source dual-energy liver CT
- Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) Lenvatinib in Differentiated Cancer of the Thyroid (SELECT)
- Pretreatment tumor thickness as a predictor of pathologic complete response to neoadjuvant chemoradiation therapy for stage II/III rectal adenocarcinoma
- Normalization of C-reactive protein levels following cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with tyrosine kinase inhibitors is associated with improved overall survival
- Budding and tumor infiltrating lymphocytes – combination of both parameters predicts survival in colorectal cancer and leads to new prognostic subgroups
ONCOLOGY
